Pharmaceutical Business Review
Return to: PBR Home | Suppliers

Haselmeier - Self-Injection Devices News

Haselmeier - Self-Injection Devices

Haselmeier: A further hit model: The Pergoveris® Pen for Merck Haselmeier has a worldwide reputation for its patient-friendly, high-tech innovations. The new Pergoveris® Pen, developed for its customer Merck, has once again confirmed the company's high standard of development.
View press release
Organizational changes in quality management at Haselmeier: Mr. Konrad Betzler becomes new CQO (Chief Quality Officer) Konrad Betzler was appointed the new Chief Quality Officer (CQO) of the entire Haselmeier Group in October 2017 with responsibility for quality management, quality assurance and all regulatory matters worldwide. As a member of the Group Executive Board, he continues to lead the Pharmaceutical Manufacturing division as Chief Pharmaceutical Officer (CPO).
View press release
Haselmeier Introduces the Award-Winning D-Flex. Just one. The especially flexible disposable pen D-Flex has been given the GOOD DESIGN™ Award. However, the D-Flex stands out in the market primarily thanks to its uniqueness. No comparable product can be deployed so flexibly and at the same time deliver patient safety.
View press release
Haselmeier AG Appoints Paul Jansen as Senior Advisor and Member of the Board of Directors Haselmeier, a leader in the development and manufacturing of drug delivery devices is pleased to announce the appointment of Paul Jansen as Senior Advisor and Member of the Board of Directors of Haselmeier AG. This appointment is a perfect fit to serve the objectives of Haselmeier AG as the innovation organization within the Haselmeier Group.
View press release
Another award for Haselmeier - the German Brand Award 2016 After the triumph of two internationally renowned accolades in 2015- the Good Design™ Award, and the Red Dot Award: Product Design 2015, Haselmeier has now also been crowned winner of the prestigious German Brand Award, 2016.
View press release
Haselmeier Group Announces the Extension and Reorganization of its Executive Board The Haselmeier Group has decided to reinforce and reorganise its Executive Board. Mr. Gert Weber has been nominated by the Board of Directors of Medico Invest AG as Chief Executive Officer (CEO) of the Haselmeier Group. This nomination is effective starting July 1st, 2015. Mr. Weber brings more than 20 years of experience in the manufacturing and technological industries and has filled various executive management positions, the last being Managing Director and Vice President responsible for Operations and Information Technology (IT) at Avnet TS (former Magirus Group). With his experience and expertise, Mr. Weber shall contribute to strengthen Haselmeier's position and performance in the medical device industry and beyond.
View press release
Haselmeier Honoured at the International Red Dot Design Award 2015: Award for High Design Quality Haselmeier is proud to announce yet another award for one of its products. Presented annually, the "Red Dot Award" is divided into three design sections. In terms of cross-border and cross-sector reach, it is considered the most distinguished accolade for high quality design. At the "Red Dot Award: Product Design 2015", Haselmeier achieved a thoroughly convincing result.
View press release
Haselmeier 2.0: Redesign of the Website Today, the world's largest and fastest provider of information is the Internet. As markets become ever more transparent, the importance of websites continues to grow - a fact Haselmeier AG recognised long ago. Its maxim of "innovation brings progress and changes thinking" will set new standards in networking and digitisation.
View press release
Haselmeier Receives Prestigious Accolade for Two of their Products: The international GOOD DESIGN™ Award 2014 Welcome news for the Haselmeier Group – two of their products scooped top prizes at the GOOD DESIGN™ Awards. This re-affirms the successful corporate philosophy of Haselmeier: The implementation of innovative ideas into high-quality products to further strengthen and expand the position of Haselmeier on the international stage.
View press release
Haselmeier Group Announces The Relocation of Haselmeier in the United States Haselmeier Inc. announced the opening of its new office in the Boott Cotton Mills at 126 John Street, Suite 11, Lowell, Ma 01852. A downtown Lowell landmark and part of the Lowell National Park, the newly restored, historic 19th century textile mill is strategically located 25 miles north of Boston, between Logan International Airport and Manchester Boston Regional Airport. The new location provides easy access for US and international clients, vendors and visitors.
View press release
New Management Organisation of the Haselmeier Group Haselmeier was able to successfully grow over the past few years, allowing the company to carve out a solid position in the market for medical devices. In keeping with this progress, the Haselmeier Group has restructured its management organisation to ensure this forward momentum continues successfully. The company has introduced a group executive board tasked with coordination and decision-making for all Haselmeier locations. The group executive board will ensure consistent, effective management of the Haselmeier sites, thereby coordinating the group's strategy.
View press release
Haselmeier announces the launch of INSUPen® EZ in India by Biocon Haselmeier announces that Biocon, one of Asia’s premier biotechnology companies, has just launched INSUPen® EZ in India. The INSUPen EZ is a second generation pen and follows on the success of Biocon’s premier insulin delivery device INSUPen®. Under the terms of the agreement between the two companies, Biocon has worldwide distribution rights to INSUPen® EZ, for use with Biocon’s insulin, Basalog™ and Insugen™, and insulin analogues.
View press release
Haselmeier Announces the Market Launch of JuniorSTAR® by Sanofi The new and reusable half-unit insulin pen JuniorSTAR® is now available in Germany. It is suitable for all insulin types of Sanofi. It provides individual dosage, which can be corrected easily. Furthermore, it has a large display to ensure the correct dosage and is a lightweight companion during the day, especially for young people with diabetes.
View press release
Haselmeier Announces the Extension of its Business Development Organisation within the Haselmeier Group Haselmeier announced the addition of Terence O’Hagan as Director of Business Development, based in the United States. Previously, he was the Senior Director of Business Development at Flextronics Medical Division, and Global Director of Strategy and Business Development at Radius Product Development.
View press release
Haselmeier Announces the CE Mark for JuniorSTAR® Half-Unit Insulin Pen Haselmeier has announced the CE Mark of JuniorSTAR® by Sanofi. JuniorSTAR® is a new easy-to-use, half‑unit insulin reusable pen that can be used with Lantus® (insulin glargine), Apidra® (insulin glulisine) or Insuman® (recombinant human insulin).
View press release
Haselmeier establishes Haselmeier Inc. in the United States Haselmeier announced today that it has established a new company in the United States, Haselmeier Inc., a fully owned subsidiary of Haselmeier GmbH. The US is a logical step in our global expansion, say Haselmeier officials, the United States is the largest healthcare market and home to many leading pharmaceutical and biotech companies.
View press release